Docusate sodium salt
SIGMA/D4422 - BioXtra, ≥99%
Synonym: AOT; Bis(2-ethylhexyl) sulfosuccinate sodium salt; Sodium bis(2-ethylhexyl) sulfosuccinate; Sulfobutanedioic acid bis(2-ethylhexyl ester) sodium salt; Sulfosuccinic acid bis(2-ethylhexyl) ester sodium salt; ‘Dioctyl’ sulfosuccinate sodium salt
CAS Number: 577-11-7
Empirical Formula (Hill Notation): C20H37NaO7S
Molecular Weight: 444.56
EC Number: 209-406-4
MDL Number: MFCD00012455
Linear Formula: C20H37NaO7S
Product Type: Chemical
| assay | ≥99% |
| cation traces | Al: ≤0.001% |
| Ca: ≤0.001% | |
| Cu: ≤0.0005% | |
| Fe: ≤0.0005% | |
| K: ≤0.01% | |
| Mg: ≤0.0005% | |
| Pb: ≤0.001% | |
| Zn: ≤0.0005% | |
| description | anionic |
| form | sheet |
| impurities | ≤0.0005% Phosphorus (P) |
| ≤0.1% Insoluble matter | |
| InChI | 1S/C20H38O7S.Na/c1-5-9-11 |
| InChI key | APSBXTVYXVQYAB-UHFFFAOYSA |
| mol wt | 444.56 g/mol |
| product line | BioXtra |
| Quality Level | 200 ![]() |
| SMILES string | [Na+].CCCCC(CC)COC(=O)CC( |
| solubility | passes test (per USP) |
| Application: | Docusate sodium salt has been used in a study to assess chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals. It has also been used in a study to investigate different formulations for drug delivery through the nail plate. |
| Application: | Forms reverse micelles in hydrocarbon solvents; Suitable for the solubilization of the major myelin transmembrane proteolipid |
| General description: | Docusate sodium salt is an anionic surfactant. |
| Packaging: | 50, 100, 500 g in poly bottle |
| Symbol | GHS05 |
| Signal word | Danger |
| Hazard statements | H315 - H318 |
| Precautionary statements | P264 - P280 - P302 + P352 - P305 + P351 + P338 - P332 + P313 - P362 + P364 |
| Hazard Codes | Xi |
| Risk Statements | 38-41 |
| Safety Statements | 26-39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Purity | ≥99% |
| UNSPSC | 12161900 |


